Does PEGLOTICASE Cause Stent placement? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Stent placement have been filed in association with PEGLOTICASE (Krystexxa). This represents 0.2% of all adverse event reports for PEGLOTICASE.
6
Reports of Stent placement with PEGLOTICASE
0.2%
of all PEGLOTICASE reports
1
Deaths
5
Hospitalizations
How Dangerous Is Stent placement From PEGLOTICASE?
Of the 6 reports, 1 (16.7%) resulted in death, 5 (83.3%) required hospitalization, and 1 (16.7%) were considered life-threatening.
Is Stent placement Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PEGLOTICASE. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does PEGLOTICASE Cause?
Gout (487)
Blood uric acid increased (359)
Infusion related reaction (284)
Therapeutic response decreased (186)
Dyspnoea (153)
Urticaria (133)
Drug ineffective (131)
Nausea (119)
Pruritus (118)
Rash (116)
What Other Drugs Cause Stent placement?
RANOLAZINE (593)
EVOLOCUMAB (244)
ADALIMUMAB (227)
ROSIGLITAZONE (196)
ETANERCEPT (174)
CLOPIDOGREL BISULFATE (167)
RIVAROXABAN (122)
ASPIRIN (118)
APIXABAN (116)
MACITENTAN (108)
Which PEGLOTICASE Alternatives Have Lower Stent placement Risk?
PEGLOTICASE vs PEGUNIGALSIDASE ALFA-IWXJ
PEGLOTICASE vs PEGVALIASE-PQPZ
PEGLOTICASE vs PEGVISOMANT
PEGLOTICASE vs PEGZEREPOETIN ALFA
PEGLOTICASE vs PEMBROLIZUMAB